Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,610 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility of reduced port surgery applying Higuchi's transverse incision.
Ueda K, Nagayoshi Y, Kawabata A, Kuroda T, Iida Y, Saitou M, Yanaihara N, Sugimoto K, Sakamoto M, Okamoto A. Ueda K, et al. Among authors: kuroda t. Gynecol Minim Invasive Ther. 2017 Jan-Mar;6(1):12-16. doi: 10.1016/j.gmit.2016.05.003. Epub 2016 Jun 15. Gynecol Minim Invasive Ther. 2017. PMID: 30254862 Free PMC article.
Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference.
Jang JYA, Yanaihara N, Pujade-Lauraine E, Mikami Y, Oda K, Bookman M, Ledermann J, Shimada M, Kiyokawa T, Kim BG, Matsumura N, Kaku T, Kuroda T, Nagayoshi Y, Kawabata A, Iida Y, Kim JW, Quinn M, Okamoto A. Jang JYA, et al. Among authors: kuroda t. J Gynecol Oncol. 2017 Jul;28(4):e54. doi: 10.3802/jgo.2017.28.e54. J Gynecol Oncol. 2017. PMID: 28541641 Free PMC article. Review.
Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers.
Ogiwara H, Takahashi K, Sasaki M, Kuroda T, Yoshida H, Watanabe R, Maruyama A, Makinoshima H, Chiwaki F, Sasaki H, Kato T, Okamoto A, Kohno T. Ogiwara H, et al. Among authors: kuroda t. Cancer Cell. 2019 Feb 11;35(2):177-190.e8. doi: 10.1016/j.ccell.2018.12.009. Epub 2019 Jan 24. Cancer Cell. 2019. PMID: 30686770 Free article.
Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients.
Hirose S, Murakami N, Takahashi K, Kuno I, Takayanagi D, Asami Y, Matsuda M, Shimada Y, Yamano S, Sunami K, Yoshida K, Honda T, Nakahara T, Watanabe T, Komatsu M, Hamamoto R, Kato MK, Matsumoto K, Okuma K, Kuroda T, Okamoto A, Itami J, Kohno T, Kato T, Shiraishi K, Yoshida H. Hirose S, et al. Among authors: kuroda t. Gynecol Oncol. 2020 Jan;156(1):203-210. doi: 10.1016/j.ygyno.2019.10.022. Epub 2019 Nov 19. Gynecol Oncol. 2020. PMID: 31757465
Vaginal Transmission of Cancer from Mothers with Cervical Cancer to Infants.
Arakawa A, Ichikawa H, Kubo T, Motoi N, Kumamoto T, Nakajima M, Yonemori K, Noguchi E, Sunami K, Shiraishi K, Kakishima H, Yoshida H, Hishiki T, Kawakubo N, Kuroda T, Kiyokawa T, Yamada K, Yanaihara N, Takahashi K, Okamoto A, Hirabayashi S, Hasegawa D, Manabe A, Ono K, Matsuoka M, Arai Y, Togashi Y, Shibata T, Nishikawa H, Aoki K, Yamamoto N, Kohno T, Ogawa C. Arakawa A, et al. Among authors: kuroda t. N Engl J Med. 2021 Jan 7;384(1):42-50. doi: 10.1056/NEJMoa2030391. N Engl J Med. 2021. PMID: 33406329
Interleukin-6 as an enhancer of anti-angiogenic therapy for ovarian clear cell carcinoma.
Seki T, Yanaihara N, Shapiro JS, Saito M, Tabata J, Yokomizo R, Noguchi D, Kuroda T, Kawabata A, Suzuki J, Takahashi K, Matsuzawa H, Miyake M, Takenaka M, Iida Y, Yanagida S, Okamoto A. Seki T, et al. Among authors: kuroda t. Sci Rep. 2021 Apr 8;11(1):7689. doi: 10.1038/s41598-021-86913-9. Sci Rep. 2021. PMID: 33833265 Free PMC article.
Clinical Features of Borderline Ovarian Seromucinous Tumor.
Nagayoshi Y, Yamada K, Kiyokawa T, Fukasawa N, Kuroda T, Noguchi D, Okamoto A. Nagayoshi Y, et al. Among authors: kuroda t. Cancer Diagn Progn. 2023 May 3;3(3):360-364. doi: 10.21873/cdp.10224. eCollection 2023 May-Jun. Cancer Diagn Progn. 2023. PMID: 37168956 Free PMC article.
1,610 results